IP Library Granted Patent US 12,290,443
Granted Patent B2
US 12,290,443 · App. 16/865,297 · Granted May 6, 2025

Implantable interpositional orthopedic pain management

Inventor: William F. Ogilvie (Austin, TX)
Assignee: Ensemble Orthopedics, Inc.
A61F2/30721A61F2/4606A61F2002/30131A61F2002/30301A61F2002/30754A61F2002/30892A61F2002/4258
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,290,443
App. No.
16/865,297
Granted
May 6, 2025
Kind
B2
Abstract

Techniques for implantable orthopedic pain management devices are disclosed, including a saddle configured to axially align a top contoured surface to a bone surface and to axially align a bottom contoured surface to another bone surface, and a peripheral protrusion disposed on a peripheral surface of the saddle, the peripheral protrusion being configured to maintain dynamic stability of the saddle between the bone surface and the another bone surface.

Claims (25)

1. An implantable device, comprising:

a substantially saddle-shaped body having a top contoured saddle surface and a bottom contoured saddle surface, the top contoured saddle surface being substantially orthogonal to the bottom contoured saddle surface, the body configured to axially align the top contoured saddle surface to a bone surface and to axially align the bottom contoured saddle surface to another bone surface and the body being configured to articulate with the bone surface and the another bone surface the top contoured saddle surface and the bottom contoured saddle surface including substantially orthogonal channels, the substantially orthogonal channels including a top channel and a bottom channel, the top contoured saddle surface having the top channel, and the bottom contoured saddle surface having the bottom channel, the top channel having a top length of curvature disposed horizontally traversed across the top contoured saddle surface, and the bottom channel having a bottom length of curvature disposed horizontally traversed across the bottom contoured saddle surfaces, such that the top length of curvature has an orientation that is substantially orthogonal to another orientation of the bottom length of curvature, each channel having channel openings, and the top and bottom channels extending between channel openings, the channel openings each being substantially concave, and each channel configured to receive one of the bone surface or the another bone surface to prevent the bone surface from contacting the another bone surface, and

a plurality of peripheral protrusions disposed on a periphery of the substantially saddle-shaped body, each of the plurality of peripheral protrusions located at a substantially corner position of the periphery; the peripheral protrusions shaped to extend in a direction of an end of the bone surface and configured to be in intermittent contact with the end of the bone surface, the peripheral protrusions being configured to permit motion of the bone surface and the another bone surface without dislocation of the body when movement of the body causes one or more of the plurality of peripheral protrusions to contact the bone surface or the another bone surface, maintain dynamic stability of the saddle-shaped body between the bone surface and the another bone surface, to prevent expulsion of the device from a cavity between the bone surface and the another bone surface, and to prevent physical contact between the bone surface and the another bone surface.

2. The implantable device of claim 1 , wherein the dynamic stability comprises maintaining anatomical alignment of the implantable device when inserted into the cavity.

3. The implantable device of claim 1 , wherein the dynamic stability comprises preventing the implantable device from being displaced, partially or entirely, from within a joint between the bone surface and the another bone surface.

4. The implantable device of claim 1 , wherein the substantially saddle-shaped body and the peripheral protrusions are substantially formed using a material comprising pyrolytic carbon.

5. The implantable device of claim 1 , wherein the substantially saddle-shaped body and the peripheral protrusions are formed using a material having one or more properties substantially similar to a property of cortical bone.

6. The implantable device of claim 1 , wherein one or more dimensions associated with the substantially saddle-shaped body are configured to be determined using a ratio generated by comparing one or more other dimensions associated with the substantially saddle-shaped body, the peripheral protrusions, the periphery, and a joint formed between the bone surface and the another bone surface.

7. The implantable device of claim 1 , wherein the peripheral protrusions are configured to prevent displacement of the implantable device from a joint formed between the bone surface and the another bone surface.

8. The implantable device of claim 1 , wherein the peripheral protrusions are disposed on the periphery at locations at which the peripheral protrusions are configured to move the implantable device in a direction that is substantially opposite to a force transmitted by the bone surface or the another bone surface.

9. The implantable device of claim 1 , wherein the peripheral protrusions are configured to prevent the implantable device from being displaced, partially or entirely, from a joint when movement between the bone surface and the another bone surface occurs.

10. The implantable device of claim 1 , wherein the peripheral protrusions are formed along the periphery.

11. The implantable device of claim 1 , wherein the peripheral protrusions are formed in the periphery, the peripheral protrusions being disposed at different positions along the periphery and configured to prevent the implantable device from being substantially dislodged from a joint formed between the bone surface and the another bone surface.

12. An implantable device, comprising:

a body having a cross sectional area that has a curvature attribute that is larger than another curvature attribute associated with a bone forming, with another bone, a joint into which the implantable device is inserted, the body having a top saddle surface and a bottom saddle surface, the top saddle surface being substantially orthogonal to the bottom saddle surface, the top saddle surface and the bottom saddle surface each having substantially orthogonal channels extending between channel openings, each channel opening located on a periphery of the body, the substantially orthogonal channels including a top channel and a bottom channel, the top saddle surface having the top channel and the bottom saddle surface having the bottom channel, the top channel having a top length of curvature disposed horizontally traversed across the top saddle surface, and the bottom channel having a bottom length of curvature disposed horizontally traversed across the bottom saddle surface, such that the top length of curvature has an orientation that is substantially orthogonal to another orientation of the bottom length of curvature, and the top and bottom channels extending between channel openings, the channel openings each being substantially concave; and

a plurality of peripheral protrusions, each of the plurality of peripheral protrusions being formed in a periphery of the body and disposed at substantially corner positions of the periphery such that each channel opening indicates an opening in between peripheral protrusions, and the plurality of peripheral protrusions being configured to be in intermittent contact with the bone or the another bone, to permit motion of the joint without dislocation of the body from the joint when at least one of the plurality of peripheral protrusions comes into contact with the bone or the another bone, and to prevent the bone from physically contacting the another bone.

13. The implantable device of claim 12 , further comprising the body being configured to be inserted into a synovial capsule substantially located within the joint.

14. The implantable device of claim 12 , wherein the cross sectional area is substantially concave while the body has another cross sectional area that is substantially orthogonal to the cross sectional area and the another cross sectional area is substantially convex.

15. The implantable device of claim 12 , wherein the joint is a carpometacarpal joint.

16. An implantable device, comprising:

a body having a substantially saddle shape, the body having a top saddle surface and a bottom saddle surface, the top saddle surface being substantially orthogonal to the bottom saddle surface, the body being configured to articulate with a bone surface of a metacarpal and the another bone surface of a trapezium within a carpometacarpal joint, and being configured to be interpositionally placed within a carpometacarpal joint to substantially maintain the articulating orientation between the metacarpal and a trapezium, the top saddle surface having a top channel and the bottom saddle surface having a bottom channel, the top channel having a top length of curvature disposed horizontally traversed across the top saddle surface, and the bottom channel having a bottom length of curvature disposed horizontally traversed across the bottom saddle surface, such that the top length of curvature has an orientation that is substantially orthogonal to another orientation of the bottom length of curvature, each channel having channel openings, and the top and bottom channels extending between channel openings, the channel openings each being substantially concave; and

a plurality of peripheral nubs formed along a periphery of the body disposed at substantially corner positions of the periphery, each of the plurality of peripheral nubs being configured to substantially stabilize the implantable device and prevent expulsion of the device from the joint when movement of the body causes at least one of the peripheral nubs comes into contact with the bone surface of the metacarpal or the another bone surface of the trapezium when inserted in the carpometacarpal joint and to prevent the metacarpal from physically cotacting the trapezium when the carpometacarpal joint is articulated.

17. The implantable device of claim 16 , wherein each of the plurality of peripheral nubs are configured to prevent expulsion of the implantable device when the metacarpal and the trapezium are articulated relative to each other.

18. The implantable device of claim 16 , wherein each of the plurality of peripheral nubs are disposed on the periphery between a portion of the metacarpal and another portion of the trapezium and are configured to generate joint distraction between the metacarpal and the trapezium when the carpometacarpal joint is articulated.

19. The implantable device of claim 16 , wherein each of the plurality of peripheral nubs are disposed on the periphery between a non-articulating portion of the metacarpal and another non-articulating portion of the trapezium and are configured to generate joint distraction between the metacarpal.

Assignments (2)
CHANGE OF NAME Recorded Aug 9, 2021
From: ENSEMBLE ORTHOPEDICS, LLC
To: ENSEMBLE ORTHOPEDICS, INC.
Reel/Frame 057123/0357 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2020
From: OGILVIE, WILLIAM F.
To: ENSEMBLE ORTHOPEDICS, LLC
Reel/Frame 052629/0866 →
Continuity (1)
Related Publication 20210338434A1 · Nov 4, 2021
References Cited (87)
US 730284A · Monosmith · 1903 [cited by applicant]
US 2642862A · Jackson · 1953 [cited by applicant]
US 4759766A · Buettner-Janz et al. · 1988 [cited by applicant]
US 5522900A · Hollister · 1996 [cited by applicant]
US 5645605A · Klawitter · 1997 [cited by applicant]
US 5702472A · Huebner · 1997 [cited by applicant]
US 6017366A · Berman · 2000 [cited by applicant]
US 6436146B1 · Hassler et al. · 2002 [cited by applicant]
US 7641696B2 · Ogilvie et al. · 2010 [cited by applicant]
US 7837739B2 · Ogilvie · 2010 [cited by applicant]
US 8012217B2 · Strzepa · 2011 [cited by examiner]
US 8100979B2 · Felt et al. · 2012 [cited by applicant]
US 8292954B2 · Robinson et al. · 2012 [cited by applicant]
US 8303664B1 · Burstein · 2012 [cited by examiner]
US 8764830B2 · Robinson et al. · 2014 [cited by applicant]
US 8852286B2 · Cook · 2014 [cited by examiner]
US 8945138B2 · Klotz et al. · 2015 [cited by applicant]
US 9237958B2 · Duggal · 2016 [cited by examiner]
US 9320609B2 · Schon et al. · 2016 [cited by applicant]
US 9408706B2 · Hassler et al. · 2016 [cited by applicant]
US 9572673B2 · Hassler et al. · 2017 [cited by applicant]
US 9707090B2 · DelSignore · 2017 [cited by applicant]
US 10064739B2 · Duggal · 2018 [cited by examiner]
US 11083587B2 · Sikora · 2021 [cited by examiner]
US 11642226B2 · Ogilvie et al. · 2023 [cited by applicant]
US 20020127264A1 · Felt · 2002 [cited by examiner]
US 20040002768A1 · Parks · 2004 [cited by examiner]
US 20040143338A1 · Burkinshaw et al. · 2004 [cited by applicant]
US 20040176773A1 · Zubok et al. · 2004 [cited by applicant]
US 20040176844A1 · Zubok et al. · 2004 [cited by applicant]
US 20050033426A1 · Ogilvie et al. · 2005 [cited by applicant]
US 20050256577A1 · Baumgartner et al. · 2005 [cited by applicant]
US 20060069446A1 · Ragusa · 2006 [cited by examiner]
US 20060241777A1 · Partin et al. · 2006 [cited by applicant]
US 20060241778A1 · Ogilvie · 2006 [cited by applicant]
US 20070100450A1 · Hodorek · 2007 [cited by applicant]
US 20070123985A1 · Errico et al. · 2007 [cited by applicant]
US 20080027550A1 · Link et al. · 2008 [cited by applicant]
US 20080269908A1 · Warburton · 2008 [cited by applicant]
US 20090012615A1 · Fell · 2009 [cited by applicant]
US 20090254190A1 · Gannoe et al. · 2009 [cited by applicant]
US 20100004743A1 · Strzepa et al. · 2010 [cited by applicant]
US 20100057213A1 · Graham et al. · 2010 [cited by applicant]
US 20100292800A1 · Zubok · 2010 [cited by applicant]
US 20110106269A1 · Warburton · 2011 [cited by applicant]
US 20110295379A1 · Shohat · 2011 [cited by applicant]
US 20120046753A1 · Cook et al. · 2012 [cited by applicant]
US 20120185056A1 · Warburton · 2012 [cited by applicant]
US 20130079877A1 · Buma et al. · 2013 [cited by applicant]
US 20130211530A1 · Mayer et al. · 2013 [cited by applicant]
US 20140194999A1 · Orbay et al. · 2014 [cited by applicant]
US 20140277552A1 · Burstein et al. · 2014 [cited by applicant]
US 20140336652A1 · Christensen et al. · 2014 [cited by applicant]
US 20150366672A1 · DelSignore · 2015 [cited by applicant]
US 20160242920A1 · Parrott et al. · 2016 [cited by applicant]
US 20160287407A1 · Patrick et al. · 2016 [cited by applicant]
US 20170056181A1 · Rosenwasser et al. · 2017 [cited by applicant]
US 20180193158A1 · Suddaby · 2018 [cited by applicant]
US 20200171202A1 · Spence et al. · 2020 [cited by applicant]
US 20210077265A1 · Garvey et al. · 2021 [cited by applicant]
US 20210338433A1 · Ogilvie · 2021 [cited by applicant]
US 20210338444A1 · Muir et al. · 2021 [cited by applicant]
US 20210338451A1 · Ogilvie et al. · 2021 [cited by applicant]
US 20210346166A1 · Sapio et al. · 2021 [cited by applicant]
US 20220079768A1 · Hotchkiss et al. · 2022 [cited by applicant]
US 20220202592A1 · Clarke et al. · 2022 [cited by applicant]
US 20220249239A1 · Williams et al. · 2022 [cited by applicant]
US 20230355395A1 · Ogilvie · 2023 [cited by applicant]
US 20240023993A1 · Ogilvie · 2024 [cited by applicant]
US 20240299175A1 · Ogilvie · 2024 [cited by applicant]
US 20240299179A1 · Ogilvie · 2024 [cited by applicant]
CH 711485A2 · 2017 [cited by applicant]
EP 2364674A1 · 2011 [cited by applicant]
EP 3128934B1 · 2019 [cited by applicant]
FR 2883723A1 · 2006 [cited by applicant]
WO 2003007841A2 · 2003 [cited by applicant]
WO 2019022712A1 · 2019 [cited by applicant]
WO 2021222907A2 · 2021 [cited by applicant]
WO 2024186934A1 · 2024 [cited by applicant]
CMC APL Suspensionplasty With InternalBrace Ligament Augmentation, Surgical Technique Guide, Arthrex, 2019, 1 Ref. # LT1-00078-EN_C, pp. 1-8, URL: https://www.arthrex.com/resources/surgical-technique-guide/x-oqu9gc1uEGT… [cited by applicant]
Hoban, Melissa A., Non-Final Office Action mailed Jan. 24, 2022 for U.S. Appl. No. 16/865,296. [cited by applicant]
Thomas, Shane, Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration, mailed Dec. 2, 2021 for International Application No. P… [cited by applicant]
Shih, Jessica G et al. “Comparison of Computed Tomography Articular Surface Geometry of Male Versus Female Thumb Carpometacarpal Joints.” Hand (New York, N.Y.) vol. 13,1 (2018): 33-39. doi: 10.1177/1558944716688528. [cited by applicant]
Hoban, Melissa A., Final Office Action mailed Sep. 14, 2022 for U.S. Appl. No. 16/865,296. [cited by applicant]
Hoban, Melissa A., Non-Final Office Action mailed May 10, 2023 for U.S. Appl. No. 16/865,296. [cited by applicant]
Stewart, Alvin J., Non-Final Office Action mailed Oct. 11, 2022 for U.S. Appl. No. 16/865,299. [cited by applicant]
Matos, Taina, Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration mailed Aug. 26, 2024 for International Application No. PC… [cited by applicant]